HEALTH

Vicks Starry Night humidifier hits retail shelves

BY Michael Johnsen

NEW YORK Kaz on Tuesday announced the launch of its Vicks Starry Night humidifier, a product that releases cool moisture into the air for temporary relief of congestion and coughs, and features a built-in, independently controlled projector so that parents have the option to turn off the lights once their child has fallen asleep without turning off the humidifier altogether.

 

With the Vicks Starry Night humidifier, parents will be able to create a virtual galaxy on their child’s bedroom ceiling.

 

 

Arecently released scientific white paper suggested humidifiers may play an important role in reducing the survival of the flu virus on both surfaces and in the air. The research suggested that homes kept between 40% and 60% relative humidity are likely to have fewer flu viruses lingering in the air and on such commonly touched surfaces as sink faucets, door handles and countertops.

 

 

Best used in medium-sized rooms, the Vicks Starry Night humidifier operates between 18 hours and 24 hours on a 1-gallon tank. The product’s built-in scent pad heater works with Vicks Soothing Vapors VapoPads.

 

 

The Vicks Starry Night Cool Moisture humidifier (V3700) has a suggested retail price of $54.99, and currently is available through Toys"R"Us, Kmart, Walgreens and on Amazon.com.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Type 2 diagnoses propel diabetes epidemic

BY Alaric DeArment

WASHINGTON —Diabetes quickly has grown into one of the top disease epidemics in the United States, with the American Diabetes Association estimating it to affect close to 24 million Americans. Growth mostly has occurred among those with Type 2 diabetes.

A report by the Agency for Healthcare Research and Quality helped show what the epidemic looks like on the ground. According to the report, released last month, there were more than 7.7 million hospital stays for patients with diabetes in 2008, resulting in $83 billion in hospital costs, or 23% of total hospital costs.

Class and geography had a lot to do with hospitalization rates, according to the report. When broken down by ZIP code, rates were higher in low-income areas than in high-income areas, with 3,232 hospitalizations per 100,000 people in the lowest-income areas, compared with 1,762 per 100,000 people in those areas with the highest incomes.

Among U.S. regions, the South had the highest rates, with 2,829 per 100,000 people hospitalized, while the West had the lowest, with 1,866 per 100,000 hospitalized. Not surprisingly, according to the Centers for Disease Control and Prevention, the South and West also have the highest and lowest rates of obesity, respectively, a major factor in the rise of Type 2 diabetes. Eight-of-the-9 states with obesity rates more than 30% as of 2009 are in the South, while 9-of-the-17 states with rates less than 25% are in the West, including Colorado, the only state in which fewer than 20% of residents are obese.

Top 10 most common principal reasons for hospitalization among patients with diabetes in 2008

*Based on all-listed diagnoses; includes % of total hospitalizations for patients with diabetes†Based on records with diabetes as a secondary diagnosis (e.g., for hospitalizations with a principal diagnosis of congestive heart failure, 41.6% have diabetes as a coexisting condition) Source: AHRQ, Center for Delivery, Organization and Markets, Healthcare Cost and Utilization Project, Nationwide Inpatient Sample, 2008
RANK PRINCIPAL DIAGNOSIS #OF HOSPITAL STAYS AMONG PATIENTS WITH DIABETES* %OF HOSPITAL STAYS WITH DIABETES AS A COEXISTING CONDITION†
1 Diabetes 519,522 (6.7%) NA
2 Congestive heart failure (nonhypertensive) 424,147 (5.5%) 41.6%
3 Coronary atherosclerosis (hardening of the arteries) 346,054 (4.5%) 37.7
4 Pneumonia 290,709 (3.8%) 25.1
5 Septicemia 224,842 (2.9%) 28.4
6 Acute myocardial infarction (heart attack) 220,760 (2.9%) 34.2
7 Chronic obstructive pulmonary disease and bronchiectasis 219,743 (2.8%) 30.7
8 Nonspecific chest pain 212,706 (2.8%) 29.3
9 Cardiac dysrhythmias 196,293 (2.5%) 24.6
10 Complication of device, implant or graft 194,516 (2.5%) 28.4

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

‘C’-ing that scars go away

BY DSN STAFF

GUILFORD, Conn. —Mitchell-Vance Labs is in the process of launching a new scar product to add to its ScarAway offering that could appeal to a whole new consumer in search of scar therapy—ScarAway for C-sections.

The therapy may have direct appeal to 1-in-4 new mothers, which is the number of women who give birth by Cesarean section in the United States. According to the March of Dimes, the national weighted average of C-section births is 25.2%, but the percentage of C-sections performed climbs higher than 30% in three states—Mississippi (31.1%), New Jersey (30.9%) and Louisiana (30.4%).

The product features an extended-length, medical-grade silicon scar sheet ideal for placement over C-section cuts.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?